Grantham, Mayo, Van Otterloo & Co (GMO)
LPNT

Grantham, Mayo, Van Otterloo & Co (GMO)’s LifePoint Health, Inc. LPNT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio LPNT Stock Details LPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,446
Closed -$710K – 731
2013
Q4 		$710K Sell
13,446
-754
-5% -$37.9K ﹤0.01% 495
2013
Q3 		$662K Sell
14,200
-1,572
-10% -$75.3K ﹤0.01% 507
2013
Q2 		$770K Buy
+15,772
New +$756K ﹤0.01% 489

Other funds holding LPNT

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s LPNT Position: Q1 2014 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of LifePoint Health, Inc. (LPNT) in Q1 2014, closing a stake of 13,446 shares — an estimated $710K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LPNT in Q2 2013 and held it in 3 quarters. The position peaked at $770K in Q2 2013. 212 funds tracked by Wall St. Rank hold LPNT as of Q1 2014.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining LifePoint Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 13,446 LifePoint Health, Inc. shares in Q1 2014, an estimated $710K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s LifePoint Health, Inc. position peaked at $770K in Q2 2013.
  • 212 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q1 2014.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2014, filed 14 May 2014.